Novartis submits application to FDA for KymriahTM (tisagenlecleucel) in adult patients with r/r DLBCL, seeking …GlobeNewswire (press release)In April 2017, Novartis received Breakthrough Therapy designation for r/r DLBCL which, if approved, would be … Continue reading
Synthetic Biology Market Promise CAGR of 32.60% During 2013 to 2019Medgadget (blog)The global synthetic biology market is projected to grow remarkably, says a report from Transparency Market Research (TMR). This report is titled “Synthetic Biology Mark… Continue reading
|
Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy
News-Medical.net Researchers have uncovered a surprising process within a key immune cell that may help explain the limitations of immunotherapy as a cancer treatment. Treg cells work within the immune system to suppress immune function. It’s a normal process: T cells … |
|
Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy
News-Medical.net Researchers have uncovered a surprising process within a key immune cell that may help explain the limitations of immunotherapy as a cancer treatment. Treg cells work within the immune system to suppress immune function. It’s a normal process: T cells … |
|
Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy
News-Medical.net Researchers have uncovered a surprising process within a key immune cell that may help explain the limitations of immunotherapy as a cancer treatment. Treg cells work within the immune system to suppress immune function. It’s a normal process: T cells … |
|
Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy
News-Medical.net Researchers have uncovered a surprising process within a key immune cell that may help explain the limitations of immunotherapy as a cancer treatment. Treg cells work within the immune system to suppress immune function. It’s a normal process: T cells … |
|
Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy
News-Medical.net Researchers have uncovered a surprising process within a key immune cell that may help explain the limitations of immunotherapy as a cancer treatment. Treg cells work within the immune system to suppress immune function. It’s a normal process: T cells … |
|
Patent dispute for CRISPR-Cas9 continues, Broad Institute denies UC claims
Daily Californian The Broad Institute filed a brief Wednesday denying many of the University of California’s patent claims on CRISPR-Cas9, a groundbreaking gene-editing technology. The Broad Institute was awarded the patent first, despite submitting its application … |